Free Trial
OTCMKTS:ATRX

Adhera Therapeutics (ATRX) Stock Price, News & Analysis

$0.0062
0.00 (0.00%)
(As of 06/24/2024 ET)
Today's Range
$0.0062
$0.0062
50-Day Range
$0.0011
$0.0089
52-Week Range
$0.00
$0.08
Volume
1 shs
Average Volume
39,439 shs
Market Capitalization
$72,571.20
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ATRX stock logo

About Adhera Therapeutics Stock (OTCMKTS:ATRX)

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

ATRX Stock Price History

ATRX Stock News Headlines

Adhera Therapeutics Inc (ATRX)
ATRX Adhera Therapeutics, Inc.
This TSLA short trade is on a nine win hot streak
Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.
Adhera Therapeutics, Inc. (ATRX)
CGTX Cognition Therapeutics, Inc.
This TSLA short trade is on a nine win hot streak
Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.
Adhera Therapeutics Announces CEO, Senior...
5 Penny Stocks with Upcoming Growth Catalysts
See More Headlines
Receive ATRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adhera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
6/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ATRX
Employees
2
Year Founded
N/A

Profitability

Net Income
$-2,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($7.02) per share

Miscellaneous

Free Float
8,348,000
Market Cap
$72,571.20
Optionable
Not Optionable
Beta
-0.30
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Andrew Albert Kucharchuk M.B.A. (Age 43)
    Vice Chairman, COO, Acting CFO & Chief Business Officer
    Comp: $285k

ATRX Stock Analysis - Frequently Asked Questions

How have ATRX shares performed in 2024?

Adhera Therapeutics' stock was trading at $0.03 at the beginning of the year. Since then, ATRX shares have decreased by 79.2% and is now trading at $0.0062.
View the best growth stocks for 2024 here
.

When did Adhera Therapeutics' stock split?

Adhera Therapeutics's stock reverse split on Thursday, October 6th 2022. The 1-20 reverse split was announced on Thursday, October 6th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Adhera Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adhera Therapeutics investors own include Achillion Pharmaceuticals (ACHN), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced BioMedical Technologies (ABMT), Abiomed (ABMD), ARCA biopharma (ABIO), Abeona Therapeutics (ABEO) and Abcam (ABCZY).

How do I buy shares of Adhera Therapeutics?

Shares of ATRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ATRX) was last updated on 6/25/2024 by MarketBeat.com Staff

From Our Partners